{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:03:56Z","timestamp":1762146236468,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010740","name":"Asahi Kasei Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.yexmp.2020.104454","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T21:58:14Z","timestamp":1589579894000},"page":"104454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fluvastatin prevents the development of arthritis in env-pX rats via up-regulation of Rho GTPase-activating protein 12"],"prefix":"10.1016","volume":"115","author":[{"given":"Shun","family":"Tanimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsunori","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Kamishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Morimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Nishibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utano","family":"Tomaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2020.104454_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000439538","article-title":"Protective effects of simvastatin and hesperidin against complete Freund\u2019s adjuvant-induced rheumatoid arthritis in rats","volume":"96","author":"Ahmed","year":"2015","journal-title":"Pharmacology"},{"key":"10.1016\/j.yexmp.2020.104454_bb0010","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s10067-015-3049-0","article-title":"Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment","volume":"34","author":"Akiyama","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0015","first-page":"1035","article-title":"Effects of simvastatin, ezetimibe, and their combination on histopathologic alterations caused by adjuvant-induced arthritis","volume":"37","author":"Barbosa","year":"2014","journal-title":"Inflammation."},{"key":"10.1016\/j.yexmp.2020.104454_bb0020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","article-title":"Pleiotropic effects of statins: new therapeutic targets in drug design","volume":"389","author":"Bedi","year":"2016","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0025","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1172\/JCI42856","article-title":"Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice","volume":"120","author":"Biswas","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2020.104454_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrrheum.2013.168","article-title":"Emerging cell and cytokine targets in rheumatoid arthritis","volume":"10","author":"Burmester","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000336","article-title":"Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study","volume":"7","author":"Chodick","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.yexmp.2020.104454_bb0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/ard.2007.083915","article-title":"Ultrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice","volume":"67","author":"Clavel","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.yexmp.2020.104454_bb0045","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4103\/0253-7613.169585","article-title":"Outcome of rheumatoid arthritis following adjunct statin therapy","volume":"47","author":"Das","year":"2015","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.yexmp.2020.104454_bb0050","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1161\/01.ATV.0000096207.01487.36","article-title":"Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2","volume":"23","author":"Deakin","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4330\/wjc.v7.i7.404","article-title":"Cholesterol confusion and statin controversy","volume":"7","author":"DuBroff","year":"2015","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature."},{"key":"10.1016\/j.yexmp.2020.104454_bb0065","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1002\/art.23986","article-title":"Antiinflammatory effect of Rho kinase blockade via inhibition of NF-\u03baB activation in rheumatoid arthritis","volume":"58","author":"He","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexmp.2020.104454_bb0070","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.ultrasmedbio.2019.04.002","article-title":"Detection of increased vascular signal in arthritis-prone rats without joint swelling using superb microvascular imaging ultrasonography","volume":"45","author":"Horie","year":"2019","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3400\/avd.ra.12.00063","article-title":"Pathogenesis of vasculitis in env-pX rats","volume":"5","author":"Ishizu","year":"2012","journal-title":"Ann. Vasc. Dis."},{"key":"10.1016\/j.yexmp.2020.104454_bb0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-4800(02)00019-9","article-title":"Transduction of dominant negative ATF-1 suppresses the pX gene expression in joint fibroblastic cells derived from HTLV-I transgenic rats","volume":"74","author":"Ishizu","year":"2003","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0085","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.38924","article-title":"Ras guanine nucleotide-releasing protein 4 is aberrantly expressed in the fibroblast-like synoviocytes of patients with rheumatoid arthritis and controls their proliferation","volume":"67","author":"Kono","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexmp.2020.104454_bb0090","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/diabetes.54.5.1514","article-title":"Low-dose poly(ADP- ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy","volume":"54","author":"Li","year":"2005","journal-title":"Diabetes."},{"key":"10.1016\/j.yexmp.2020.104454_bb0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0100","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.ultrasmedbio.2016.03.031","article-title":"Efficacy of combined ultrasound-and-microbubbles-mediated diclofenac gel delivery to enhance transdermal permeation in adjuvant-induced rheumatoid arthritis in the rat","volume":"42","author":"Liao","year":"2016","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/35044547","article-title":"Rho GTPases in neuronal morphogenesis","volume":"1","author":"Luo","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.yexmp.2020.104454_bb0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.arcmed.2010.04.005","article-title":"In vitro modulation of peroxisome proliferator-activated receptor-gamma and its genes by C-reactive protein. Role of atorvastatin","volume":"41","author":"Mahajan","year":"2010","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.yexmp.2020.104454_bb0115","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.yexmp.2020.104454_bb0120","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2020.104454_bb0125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yexmp.2020.104454_bb0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/art.21564","article-title":"Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis","volume":"54","author":"Nagashima","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexmp.2020.104454_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/s10165-009-0183-z","article-title":"Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"19","author":"Nanke","year":"2009","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0140","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.2165\/00003495-200767150-00001","article-title":"Role of HMG-CoA reductase inhibitors in neurological disorders: progress to date","volume":"67","author":"Reiss","year":"2007","journal-title":"Drugs."},{"key":"10.1016\/j.yexmp.2020.104454_bb0145","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1038\/ncomms9623","article-title":"Phosphoinositide 3-kinase enables phagocytosis of large particles by terminating actin assembly through Rac\/Cdc42 GTPase-activating proteins","volume":"6","author":"Schlam","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2020.104454_bb0150","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","article-title":"Rho GTPases and signaling networks","volume":"11","author":"Van Aelst","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexmp.2020.104454_bb0155","doi-asserted-by":"crossref","first-page":"23b","DOI":"10.1016\/S0002-9149(02)03270-8","article-title":"Prevention of stroke and dementia with statins: effects beyond lipid lowering","volume":"91","author":"Vaughan","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0160","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2174\/138920101506140910150612","article-title":"The use of biologic therapies in the treatment of rheumatoid arthritis","volume":"15","author":"Wang","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.yexmp.2020.104454_bb0165","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.1073\/pnas.89.20.9784","article-title":"Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis","volume":"89","author":"Williams","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2020.104454_bb0170","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1002\/art.22169","article-title":"RhoA-mediated, tumor necrosis factor \u03b1-induced activation of NF-\u03baB in rheumatoid synoviocytes: inhibitory effect of simvastatin","volume":"54","author":"Xu","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexmp.2020.104454_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCRESAHA.107.163493","article-title":"Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency","volume":"102","author":"Yagi","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexmp.2020.104454_bb0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/intimm\/9.2.339","article-title":"A wide spectrum of collagen vascular and autoimmune diseases in transgenic rats carrying the env-pX gene of human T lymphocyte virus type I","volume":"9","author":"Yamazaki","year":"1997","journal-title":"Int. Immunol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480020300629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480020300629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:59:48Z","timestamp":1762145988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480020300629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":36,"alternative-id":["S0014480020300629"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2020.104454","relation":{},"ISSN":["0014-4800"],"issn-type":[{"type":"print","value":"0014-4800"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluvastatin prevents the development of arthritis in env-pX rats via up-regulation of Rho GTPase-activating protein 12","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2020.104454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104454"}}